Legend Biotech Files Routine 6-K Disclosure
Ticker: LEGN · Form: 6-K · Filed: Jul 26, 2024 · CIK: 1801198
| Field | Detail |
|---|---|
| Company | Legend Biotech Corp (LEGN) |
| Form Type | 6-K |
| Filed Date | Jul 26, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, routine-disclosure, foreign-private-issuer
TL;DR
Legend Biotech filed a 6-K, just a routine check-in with the SEC, no big news here.
AI Summary
Legend Biotech Corporation filed a Form 6-K on July 26, 2024, to report its status as a foreign private issuer filing annual reports under Form 20-F. The filing does not contain specific financial figures or operational updates but serves as a routine disclosure.
Why It Matters
This filing is a standard procedural document for foreign private issuers, indicating Legend Biotech is adhering to its reporting obligations with the SEC.
Risk Assessment
Risk Level: low — The filing is a routine procedural disclosure and does not contain new material information that would typically impact risk.
Key Players & Entities
- Legend Biotech Corporation (company) — Filer of the Form 6-K
- July 26, 2024 (date) — Date of the report
- Form 6-K (document) — Type of SEC filing
- Form 20-F (document) — Annual report form for foreign private issuers
FAQ
What is the purpose of this Form 6-K filing by Legend Biotech Corporation?
The Form 6-K filed on July 26, 2024, serves as a Report of Foreign Private Issuer, indicating that Legend Biotech is submitting its required disclosures to the SEC.
Does this filing contain specific financial results or operational updates?
No, this particular Form 6-K filing does not appear to contain specific financial results or operational updates; it is a procedural disclosure.
What does it mean that Legend Biotech files under Form 20-F?
Filing under Form 20-F signifies that Legend Biotech is a foreign private issuer and is providing its annual report disclosures in that format, as indicated by the checkmark in the filing.
What is the principal executive office address for Legend Biotech?
The principal executive office address for Legend Biotech Corporation is 2101 Cottontail Lane, Somerset, New Jersey 08873.
What is the Commission File Number for Legend Biotech?
The Commission File Number for Legend Biotech Corporation is 001-39307.
Filing Stats: 599 words · 2 min read · ~2 pages · Grade level 15.6 · Accepted 2024-07-26 07:00:06
Filing Documents
- f6k_072624.htm (6-K) — 9KB
- exh_991.htm (EX-99.1) — 11KB
- 0001171843-24-004161.txt ( ) — 21KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Legend Biotech Corporation (Registrant) Date: July 26, 2024 /s/ Ying Huang Ying Huang, Ph.D. Chief Executive Officer